Pershing Square Ups Stake In Valeant Pharmaceuticals (VRX)

  • Pershing Square acquires 2,144,618 shares of Valeant Pharmaceuticals (VRX) from 1-Oct-15 to 23-Nov-15
  • Total cost: $240,933,692

pershing square purchase of valeant pharmaceuticals stock shares table

  • Pershing Square sells strangles to fund purchases of OTM calls; first on 20-Nov-15 and then again on 23-Nov-15
  • Total exposure through options: 12,500,000 shares; total cost: $65,561,919
  • Total additions: 14,644,618 shares; total cost: $306,495,611

pershing square options on valeant pharmceutical vrx table

  • Pershing Square total stake: 9.9% (34.12 mln shares)


Here’s the latest snippet from a zerohedge post:

zerohedge article quote on pershing square stake in valeant pharmaceuticals

  • Average cost: $113.76
  • Valeant Pharmaceuticals (VRX) current stock price: $87.34 (source: Google Finance; 7:59PM – Nov23’15)

valeant pharmaceuticals vrx stock chart with pershing square purchases november 23

Thanks for reading.


Twitter:  @sobata416

Any opinions expressed herein are solely those of the author, and do not in any way represent the views or opinions of any other person or entity.


Sign up for our FREE newsletter
and receive our best trading ideas and research